Puma Biotechnology
PBYI
PBYI
117 hedge funds and large institutions have $356M invested in Puma Biotechnology in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
-5
Holders Change %
-4.1%
% of All Funds
2.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
44
Reduced
43
Closed
15
Calls
$726K
Puts
$569K
Net Calls
+$157K
Net Calls Change
-$978K
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
$357K |
| 2 |
SI
Sofinnova Investments
Menlo Park,
California
|
$3.35M |
| 3 |
JGC
J. Goldman & Co
New York
|
$0 |
| 4 |
Axa
Paris,
France
|
$0 |
| 5 |
DM
Deerfield Management
New York
|
$36.6M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Wolverine Trading
Chicago,
Illinois
| – | -$154K | -14,810 | Closed |
|
|
GTCM
127
Gyon Technologies Capital Management
Denville,
New Jersey
| – | -$144K | -14,054 | Closed |
|
|
ASN
128
Advisory Services Network
Atlanta,
Georgia
| – | -$75K | -7,275 | Closed |
|
|
MC
129
Maverick Capital
Dallas,
Texas
| – | -$48K | -4,720 | Closed |
|
|
APC
130
Aspire Private Capital
Cornelius,
North Carolina
| – | -$5K | -500 | Closed |
|
|
IA
131
Inspire Advisors
Meridian,
Idaho
| – | -$1K | -49 | Closed |
|